Katherine L. Widnell

3.9k total citations · 1 hit paper
14 papers, 1.5k citations indexed

About

Katherine L. Widnell is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Katherine L. Widnell has authored 14 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 4 papers in Psychiatry and Mental health. Recurrent topics in Katherine L. Widnell's work include Neuroscience and Neuropharmacology Research (6 papers), Migraine and Headache Studies (4 papers) and Receptor Mechanisms and Signaling (4 papers). Katherine L. Widnell is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Migraine and Headache Studies (4 papers) and Receptor Mechanisms and Signaling (4 papers). Katherine L. Widnell collaborates with scholars based in United States, Germany and Sweden. Katherine L. Widnell's co-authors include Eric J. Nestler, Bruce T. Hope, David Russell, E J Nestler, Ahmed A. Othman, Alberto J. Espay, Robert Lenz, Yili Pritchett, Krai Chatamra and Janet Benesh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and Neurology.

In The Last Decade

Katherine L. Widnell

14 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

2013 487 citations C. Warren Olanow, Karl Kieburtz et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katherine L. Widnell United States	11	756	537	452	167	152	14	1.5k
Lisa Gauger United States	12	879 1.2×	718 1.3×	492 1.1×	89 0.5×	43 0.3×	16	1.4k
Daniel M. Togasaki United States	18	742 1.0×	795 1.5×	265 0.6×	149 0.9×	92 0.6×	25	1.3k
Christos Koros Greece	20	265 0.4×	642 1.2×	204 0.5×	253 1.5×	63 0.4×	64	1.1k
Melissa J. Nirenberg United States	23	1.4k 1.9×	1.2k 2.3×	817 1.8×	121 0.7×	149 1.0×	45	2.7k
L. Rouquier France	15	872 1.2×	545 1.0×	433 1.0×	130 0.8×	263 1.7×	18	1.6k
Bo-Kyun Kim South Korea	15	264 0.3×	159 0.3×	167 0.4×	245 1.5×	137 0.9×	55	1.0k
Fabrice Trovero France	18	1.0k 1.3×	135 0.3×	708 1.6×	200 1.2×	157 1.0×	40	1.8k
Belén Gago Spain	21	654 0.9×	332 0.6×	439 1.0×	174 1.0×	78 0.5×	47	1.1k
Robert J. Fenster United States	10	519 0.7×	130 0.2×	514 1.1×	151 0.9×	78 0.5×	12	1.4k
Niels Hansen Germany	19	459 0.6×	274 0.5×	178 0.4×	190 1.1×	141 0.9×	35	1.0k

Countries citing papers authored by Katherine L. Widnell

Since Specialization

Citations

This map shows the geographic impact of Katherine L. Widnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine L. Widnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine L. Widnell more than expected).

Fields of papers citing papers by Katherine L. Widnell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine L. Widnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine L. Widnell. The network helps show where Katherine L. Widnell may publish in the future.

Co-authorship network of co-authors of Katherine L. Widnell

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine L. Widnell. A scholar is included among the top collaborators of Katherine L. Widnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine L. Widnell. Katherine L. Widnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Tepper, Stewart J., Katherine L. Widnell, David Doležil, et al.. (2017). Evaluating the Efficacy and Safety of Erenumab (AMG 334) In Chronic Migraine Prevention in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Study (S52.002). Neurology. 88(16_supplement). 1 indexed citations

Kawata, Ariane K., Asha Hareendran, Randall H. Bender, et al.. (2017). Evaluating the Measurement Properties of a New Instrument-the Migraine Physical Function Impact Diary (MPFID) (P2.156). Neurology. 88(16_supplement). 1 indexed citations

Bonafede, Machaon, Qian Cai, Katherine Cappell, et al.. (2017). Factors Associated with Direct Health Care Costs Among Patients with Migraine. Journal of Managed Care & Specialty Pharmacy. 23(11). 1169–1176. 32 indexed citations

Mannix, Sally, Anne Skalicky, Dawn C. Buse, et al.. (2016). Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches. Health and Quality of Life Outcomes. 14(1). 143–143. 60 indexed citations

Olanow, C. Warren, Karl Kieburtz, Per Odin, et al.. (2013). Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. The Lancet Neurology. 13(2). 141–149. 487 indexed citations breakdown →

Widnell, Katherine L.. (2005). Pathophysiology of motor fluctuations in Parkinson's disease. Movement Disorders. 20(S11). S17–S22. 46 indexed citations

Widnell, Katherine L. & Cynthia L. Comella. (2005). Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations. Movement Disorders. 20(S11). S30–S37. 25 indexed citations

Yan, Ni, Katherine L. Widnell, Jingshan Chen, et al.. (1998). Cell Type‐Specific Regulation of CREB Gene Expression: Mutational Analysis of CREB Promoter Activity. Journal of Neurochemistry. 71(5). 1865–1874. 33 indexed citations

Widnell, Katherine L., Jingshan Chen, Philip A. Iredale, et al.. (1996). Transcriptional Regulation of CREB (Cyclic AMP Response Element‐Binding Protein) Expression in CATH.a Cells. Journal of Neurochemistry. 66(4). 1770–1773. 24 indexed citations

10.

Widnell, Katherine L., David W. Self, Sarah Lane, et al.. (1996). Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens.. Journal of Pharmacology and Experimental Therapeutics. 276(1). 306–315. 130 indexed citations

11.

Iredale, Philip A., Rose Z. Terwilliger, Katherine L. Widnell, E J Nestler, & Ronald S. Duman. (1996). Differential regulation of corticotropin-releasing factor1 receptor expression by stress and agonist treatments in brain and cultured cells.. Molecular Pharmacology. 50(5). 1103–1110. 61 indexed citations

12.

Russell, David, Katherine L. Widnell, & Eric J. Nestler. (1996). Antisense Oligonucleotides: New Tools for the Study of Brain Function. The Neuroscientist. 2(2). 79–82. 10 indexed citations

13.

Widnell, Katherine L., David Russell, & E J Nestler. (1994). Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro.. Proceedings of the National Academy of Sciences. 91(23). 10947–10951. 103 indexed citations

14.

Nestler, Eric J., Bruce T. Hope, & Katherine L. Widnell. (1993). Drug addiction: A model for the molecular basis of neural plasticity. Neuron. 11(6). 995–1006. 452 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact